Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA: 688076)

Jiangsu Sinopep-Allsino Biopharmaceutical Revenue

Jiangsu Sinopep-Allsino Biopharmaceutical had revenue of 475.68M CNY in the quarter ending June 30, 2024, with 146.82% growth. This brings the company's revenue in the last twelve months to 1.46B, up 86.82% year-over-year. In the year 2023, Jiangsu Sinopep-Allsino Biopharmaceutical had annual revenue of 1.03B with 58.69% growth.

• Revenue (ttm): 1.46B
• Revenue Growth: +86.82%
• P/S Ratio: 8.83
• Revenue / Employee: 823.08K
• Employees: 1,545
• Market Cap: 13.10B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.03B	382.26M	58.69%
Dec 31, 2022	651.29M	7.42M	1.15%
Dec 31, 2021	643.87M	77.00M	13.58%
Dec 31, 2020	566.87M	195.34M	52.58%
Dec 31, 2019	371.53M	116.00M	45.40%